Article info

Download PDFPDF
Systematic review
Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer–related or all-cause mortality but results likely due to heterogeneity – the two highest quality studies identified do find prostate cancer–related mortality reductions
  1. Correspondence to Monique J Roobol
    Erasmus University Medical Center, Rotterdam, The Netherlands; m.roobol{at}erasmusmc.nl
View Full Text

Citation

Roobol MJ, Carlsson S, Hugosson J
Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer–related or all-cause mortality but results likely due to heterogeneity – the two highest quality studies identified do find prostate cancer–related mortality reductions

Publication history

  • First published January 12, 2011.
Online issue publication 
January 20, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.